SurfWax News Index  |  Track News  |  Save/Exchange Information |  WikiWax |  About Us

    News and Articles on Questcor Pharmaceuticals (QSC)


      CBS Marketwatch
    Quote
    Chart
    Yahoo! Finance:
    Profile
    Key Statistics
    SEC Filings
    MSN Money
    Earnings Estimates
    Financial Results
    Insider Trading
     

    New Discovery To Aid In Diagnosis And Treatment Of Kidney Disease  Jul 10, 2009
    One author (Beck) reports receiving grant support from Amgen and having a patent pending for a diagnostic immunoassay to detect anti-PLA2R antibodies in membranous nephropathy; another author (Lambeau) is holding patents related to the therapeutic use of secretory PLA2 proteins and their inhibitors; and another author (Salant) receives consulting fees from Questcor Pharmaceuticals, Cormedix, and DiObix and has a patent pending for a diagnostic immunoassay to detect anti-PLA2R antibodies in... (Science Daily)

    Semi-Annual Changes to the NASDAQ Biotechnology Index  May 9, 2009
    Questcor Pharmaceuticals, Inc. (NasdaqGM: - ) develops and commercializes novel central nervous system-focused therapeutics that address significant unmet medical needs. The Company's primary product is a natural source adrenocorticotropic hormone indicated for the treatment of acute exacerbations of multiple sclerosis, as well as a number of other conditions. (Primezone Releases)

    Questcor Announces First Quarter 2009 Earnings Release Date and Conference Call  Apr 20, 2009
    Press Release Source: Questcor Pharmaceuticals ... April 20, 2009 (GLOBE NEWSWIRE) -- Questcor Pharmaceuticals, Inc. (NasdaqGM: - ) today announced that it will release financial results for the first quarter ended March 31, 2009 on Tuesday, April 28, 2009 after the market close ... To access the live webcast of the call, go to Questcor Pharmaceuticals' website at. (Primezone Releases)

    Questcor to Present At Cowen and Company 29th Annual Health Care Conference  Mar 12, 2009
    Source: Questcor Pharmaceuticals ... March 12, 2009 (GLOBE NEWSWIRE) -- Questcor Pharmaceuticals, Inc. (NasdaqGM: - ) announced today that it will present at the Cowen and Company 29th Annual Health Care Conference on Tuesday, March 17, 2009, at The Boston Marriott Copley Place ... Questcor Pharmaceuticals, Inc. is a pharmaceutical company that markets two commercial products, H.P. Acthar(r) Gel (``Acthar'') and Doral(r). (Primezone Releases)




    Back to Company News News

[ Terms Of Use | Privacy | About ]
©1998-2006 SurfWax, Inc.
All rights reserved. Patents pending.



Copyright SurfWax, Inc. 2006